Biotech
LYON, FRANCE: Product Revenue Guidance for 2015 of $170-$185 Million Reaffirmed; Conference Call With Management to Take Place at 10:00 AM ET on May 15, 2015
...
NORWOOD, MA: Dr. Serhan Is a Leading Scientific Authority in Inflammatory Resolution
...
MENLO PARK, CA: Early Results Published in 2015 American Society of Clinical Oncology (ASCO) Annual Meeting Program
...
LAVAL, QUEBEC: - Product platform expected to generate additional plasma-derived orphan drugs in 2015 - 2 PBI-4050 Phase II clinical trials expected to produce efficacy data in patients during 2015 - Expansion of cl ...
SEATTLE, WA: Achieves Total Revenue for Q1 2015 of $1.9 Million; Conference Call to Be Held Today at 4:30 pm Eastern Time
...
NEEDHAM, MA: A Plenary Session at the 2015 Next Generation Dx Summit in Washington, DC Will Connect Diagnostics Professionals From Across the Industry for Guidance on Two Significant Changes in IVD Approval and Re ...
LAVAL, QUEBEC: - Net loss of $20.4M after expensing $9.9M of R&D and $9.5M of non-cash, accounting adjustments - PBI-4050 cleared by Health Canada to commence clinical trials in both metabolic syndrome and resul ...
NORWOOD, MA: First Quarter Marked by Significant Progress on Operational, Clinical and Regulatory Milestones Company Expects to Commence Phase 2 Clinical Studies of Resunab in Scleroderma in 2Q 2015 and Cystic Fib ...
